Forms Processing
PRODUCTS
-
Preparing regulatory marketing applications to their successful conclusions is our focus.
-
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
Technology solutions for life sciences that get products to market quickly and efficiently.
-
At ProPharma, our Cell and Gene Therapy consulting team offers a comprehensive and integrated approach to early-stage cell and gene therapy development. Our expert team provides a range of services, including IND/CTA preparation, manufacturing technology, safety and risk assessment, and development planning, to help our clients navigate the complex and ever-changing landscape of cell and gene therapy development.
-
Physiologix human growth factor concentrate is a cGMP, xeno-free media supplement for stem cells and T cells that replaces FBS or human serum in media formulations.
WHITE PAPERS AND CASE STUDIES
-
Orthogonal Methods To Understand And Define CQAs Of AAV Therapies
An essential part of AAV vector production is the characterization of potential CQAs. Learn about novel, robust, and orthogonal methods that can be used to assess identity, purity, and residuals.
-
Site Satisfaction: Influencing Tech Development Strategies
Technology is playing an increasingly important role in clinical trials, helping to improve efficiency, compliance, and data quality. Learn why it’s critical that clinical study technologies are easy to use across sites and fit into the team’s workflows.
-
Improve Your Molecular Cloning Process With Synthetic Biology Automation
Explore the promising field of synthetic biology, the hurdles manufacturers face with it's workflow, and how automation can help accelerating throughput and walkaway time.
-
Leveraging The Bolar Exemption To Accelerate Market Access
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.
-
Full Scale Operations For Parenteral Pharmaceuticals
Explore how a project team accelerated through milestones in development, approval and execution of Equipment Evaluations, Equipment Specification Documents, Installation Qualification, and Operational Qualifications.
-
Solving The EHR-To-EDC Challenge: A Scalable-First Approach
Unearth how industry shifts, technology adoption, and interoperability openness are paving the way for scalable solutions.
-
Metastatic Breast Cancer Rates Show Disparities Between Black And White Patients
Given that age and screening have observable but not fully explicable effects on risk, a new analysis investigates the racial disparities in breast cancer outcomes.
-
From Paper To Digital Study Management In Large Patient Registries
Uncover how this sponsor was able to independently design and oversee its clinical study, minimizing external assistance, and easing the workload for their sites through mobile app accessibility.
-
BMS Adopts A New Clinical Data Architecture
Learn how Bristol Myers Squibb was able to optimize data review processes to streamline and improve access to clinical trial records.
-
Establishing Analytical Methods For mRNA-Based Therapies
Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
Revolutionizing Lead Service Line Removal: A Milestone For Detroit's Water Infrastructure
Detroit, like many other cities across the U.S., has grappled with a silent threat lurking within its aging water infrastructure: lead service lines. Learn why The Detroit Water and Sewage Department partnered with BlueConduit to help make the lead service line inventory and removal process more efficient than ever before.
NEWS
-
Research Collaboration Between RIT And Cornell Produces New Technique To Enhance Sensors And Photonic Devices1/30/2025
Researchers have discovered new ways to bend light to improve optical applications such as sensors, displays, and next-generation photonic devices.
-
Laser-Based Artificial Neuron Mimics Nerve Cell Functions At Lightning Speed12/19/2024
Researchers have developed a laser-based artificial neuron that fully emulates the functions, dynamics and information processing of a biological graded neuron.
-
Quark Embeds AI To Convert Unstructured Into Structured Content In Newest Release Of Quark Publishing Platform NextGen4/17/2024
Quark Software, the global provider of content automation, intelligence and design software, today announced the newest release of Quark Publishing Platform (QPP) NextGen, its cloud-based content automation platform that simplifies the complexities associated with the entire enterprise content lifecycle management process, from creation to consumption, in a fully integrated CCMS.
-
ADNEC Group Introduces Smart Parking System To Enhance Visitor Experience At The ADNEC Centre Abu Dhabi6/13/2025
ADNEC Group, a Modon Company, has launched a new smart parking system at ADNEC Centre Abu Dhabi, a project aimed to leverage the experience for the venue’s annual 3 million visitors.
-
EY US Unveils Dr. Martin Gross Of Gross-Wen Technologies As An Entrepreneur Of The Year 2025 Heartland Award Finalist4/23/2025
Ernst & Young LLP (EY US) announced the finalists for the prestigious Entrepreneur Of The Year 2025 Heartland Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and making a profound impact on communities.